发明公开
EP1223174A3 Processes for preparation of 3-keto-7alpha-alkoxycarbonyl-delta-4,5- steroids and intermediates useful therein
失效
一种用于3-酮 - 7alpha烷氧羰Delta4,5甾体和其中间体的制备方法
- 专利标题: Processes for preparation of 3-keto-7alpha-alkoxycarbonyl-delta-4,5- steroids and intermediates useful therein
- 专利标题(中): 一种用于3-酮 - 7alpha烷氧羰Delta4,5甾体和其中间体的制备方法
-
申请号: EP02007309.4申请日: 1997-12-11
-
公开(公告)号: EP1223174A3公开(公告)日: 2005-03-16
- 发明人: Ng, John S. , Liu, Chin , Anderson, Dennis K. , Lawson, Jon P. , Wieczorek, Joseph , Kunda, Sastry A. , Letendre, Leo J. , Pozzo, Marc J. , Sing, Yuen-Lung L. , Wang, Ping T. , Yonan, Edward E. , Weier, Richard M. , Kowar, Thomas R. , Baez, Julio A. , Erb, Bernhard
- 申请人: G.D. SEARLE & CO.
- 申请人地址: P.O. Box 5110 Chicago, IL 60680-5110 US
- 专利权人: G.D. SEARLE & CO.
- 当前专利权人: G.D. SEARLE & CO.
- 当前专利权人地址: P.O. Box 5110 Chicago, IL 60680-5110 US
- 代理机构: Strych, Werner Dr.
- 优先权: US33315P 19961211; US49388P 19970611
- 主分类号: C07J1/00
- IPC分类号: C07J1/00 ; C07J21/00 ; C07J41/00 ; C07J71/00 ; C12P33/00 ; C07D301/12 ; C07J31/00 ; C07J53/00 ; C12P33/10
摘要:
Multiple novel reaction schemes, novel process steps and novel intermediates are provided for the synthesis of epoxymexrenone and other compounds of Formula I wherein: -A-A- represents the group -CHR4-CHR5- or -CR4=CR5- R3, R4 and R5 are independently selected from the group consisting of hydrogen, halo, hydroxy, lower alkyl, lower alkoxy, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, cyano, varyloxy; R1 represents an alpha-oriented lower alkoxycarbonyl or hydroxyalkyl radical; -B-B- represents the group -CHR6-CHR7- or an alpha- or beta- oriented group: where R6 and R7 are independently selected from the group consisting of hydrogen, halo, lower alkoxy, acyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, acyloxyalkyl, cyano and aryloxy; and R8 and R9 are independently selected from the group consisting of hydrogen, hydroxy, halo, lower alkoxy, acyl, hydroxyalkyl, alkoxyalkyl, hydroxycarbonyl, alkyl, alkoxycarbonyl, acyloxyalkyl, cyano and aryloxy, or R8 and R9 together comprise a carbocyclic or heterocyclic ring structure, or R8 or R9 together with R6 or R7 comprise a carbocyclic or heterocyclic ring structure fused to the pentacyclic D ring.
公开/授权文献
信息查询